amiodarone has been researched along with Aortic Stenosis in 10 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether prophylactic amiodarone infusion prevents ventricular fibrillation after aortic cross-clamp release and attenuates cytokine production in patients with left ventricular hypertrophy undergoing cardiac surgery." | 9.30 | Prophylactic Effect of Amiodarone Infusion on Reperfusion Ventricular Fibrillation After Release of Aortic Cross-Clamp in Patients with Left Ventricular Hypertrophy Undergoing Aortic Valve Replacement: ARandomized Controlled Trial. ( Kagaya, S; Kuroda, M; Mita, N; Miyoshi, S, 2019) |
| "Amiodarone is widely used in Europe and the United States for refractory ventricular fibrillation (VF) in various situations, such as VF after myocardial infarction or out-of-hospital cardiac arrest." | 7.76 | [Successful use of intravenous amiodarone for refractory ventricular fibrillation just after releasing aortic cross-clamp]. ( Iwasaki, T; Kanazawa, T; Matsuoka, M; Morimatsu, H; Morita, K; Shimizu, K; Suemori, T; Suzuki, S; Toda, Y; Yokoi, N, 2010) |
| "To investigate whether prophylactic amiodarone infusion prevents ventricular fibrillation after aortic cross-clamp release and attenuates cytokine production in patients with left ventricular hypertrophy undergoing cardiac surgery." | 5.30 | Prophylactic Effect of Amiodarone Infusion on Reperfusion Ventricular Fibrillation After Release of Aortic Cross-Clamp in Patients with Left Ventricular Hypertrophy Undergoing Aortic Valve Replacement: ARandomized Controlled Trial. ( Kagaya, S; Kuroda, M; Mita, N; Miyoshi, S, 2019) |
| "Amiodarone is widely used in Europe and the United States for refractory ventricular fibrillation (VF) in various situations, such as VF after myocardial infarction or out-of-hospital cardiac arrest." | 3.76 | [Successful use of intravenous amiodarone for refractory ventricular fibrillation just after releasing aortic cross-clamp]. ( Iwasaki, T; Kanazawa, T; Matsuoka, M; Morimatsu, H; Morita, K; Shimizu, K; Suemori, T; Suzuki, S; Toda, Y; Yokoi, N, 2010) |
| "1." | 1.29 | Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. ( Borrel, E; Fagret, D; Vanzetto, G; Wolf, JE, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seto, AH | 1 |
| Abbott, NJ | 1 |
| Makkar, RR | 1 |
| Salazar, MA | 1 |
| Mita, N | 1 |
| Kagaya, S | 1 |
| Miyoshi, S | 1 |
| Kuroda, M | 1 |
| Dalia, AA | 1 |
| Essandoh, MK | 1 |
| Jackson, MW | 1 |
| Taylor, RJ | 1 |
| Morita, Y | 1 |
| Mizuno, J | 1 |
| Yoshimura, T | 1 |
| Morita, S | 1 |
| Suzuki, S | 1 |
| Iwasaki, T | 1 |
| Morimatsu, H | 1 |
| Yokoi, N | 1 |
| Matsuoka, M | 1 |
| Suemori, T | 1 |
| Kanazawa, T | 1 |
| Shimizu, K | 1 |
| Toda, Y | 1 |
| Morita, K | 1 |
| Modi, S | 1 |
| Foster, W | 1 |
| Todd, DM | 1 |
| Klein, GJ | 1 |
| Merz, T | 1 |
| Fuller, SH | 1 |
| Fagret, D | 1 |
| Wolf, JE | 1 |
| Vanzetto, G | 1 |
| Borrel, E | 1 |
| Pethig, K | 1 |
| Wahlers, T | 1 |
| Tager, S | 1 |
| Borst, HG | 1 |
1 review available for amiodarone and Aortic Stenosis
| Article | Year |
|---|---|
Postoperative wide complex tachycardia: an alternative hypothesis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Atrial Fibrillation; Electrocardiog | 2013 |
1 trial available for amiodarone and Aortic Stenosis
| Article | Year |
|---|---|
Prophylactic Effect of Amiodarone Infusion on Reperfusion Ventricular Fibrillation After Release of Aortic Cross-Clamp in Patients with Left Ventricular Hypertrophy Undergoing Aortic Valve Replacement: ARandomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Double-Blind Met | 2019 |
8 other studies available for amiodarone and Aortic Stenosis
| Article | Year |
|---|---|
Sustained left ventricular outflow tract ventricular tachycardia following transcatheter aortic valve replacement.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Electrocardiography; H | 2017 |
Preventing Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Aortic Valve Replacement: Time to Consider Prophylactic Amiodarone Infusion.
Topics: Amiodarone; Aortic Valve; Aortic Valve Stenosis; Heart Valve Prosthesis; Humans; Hypertrophy, Left V | 2019 |
New-Onset Heart Failure in a Patient With a Pacemaker: An Unusual Cause.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Atrial Fibrillation; Bisoprolol; Ca | 2016 |
Efficacy of amiodarone on refractory ventricular fibrillation resistant to lidocaine and cardioversion during weaning from cardiopulmonary bypass in aortic valve replacement for severe aortic stenosis with left ventricular hypertrophy.
Topics: Aged; Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Aortic Valve; Aortic Valve Stenosis; | 2010 |
[Successful use of intravenous amiodarone for refractory ventricular fibrillation just after releasing aortic cross-clamp].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Cardiopulmonary Bypass; Humans; Inj | 2010 |
Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone.
Topics: Aged; Alanine Transaminase; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve; Aortic Valve Stenosis; | 2007 |
Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Amiodarone; Aortic Valve Stenosis; Contrast Media; Digoxin; Fema | 1993 |
Perioperative complications in combined aortic valve replacement and extraanatomic ascending-descending bypass.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aorta; Aorta, Thoracic; Aortic Coarctation; Aortic Valve; Aortic | 1996 |